Stimulus-Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy

Adv Sci (Weinh). 2024 Jan;11(1):e2306152. doi: 10.1002/advs.202306152. Epub 2023 Nov 20.

Abstract

Deregulated inflammations induced by various factors are one of the most common diseases in people's daily life, while severe inflammation can even lead to death. Thus, the efficient treatment of inflammation has always been the hot topic in the research of medicine. In the past decades, as a potential biomaterial, stimuli-responsive hydrogels have been a focus of attention for the inflammation treatment due to their excellent biocompatibility and design flexibility. Recently, thanks to the rapid development of nanotechnology and material science, more and more efforts have been made to develop safer, more personal and more effective hydrogels for the therapy of some frequent but tough inflammations such as sepsis, rheumatoid arthritis, osteoarthritis, periodontitis, and ulcerative colitis. Herein, from recent studies and articles, the conventional and emerging hydrogels in the delivery of anti-inflammatory drugs and the therapy for various inflammations are summarized. And their prospects of clinical translation and future development are also discussed in further detail.

Keywords: drug delivery; immune responses; inflammation targeted therapy; inflammatory microenvironments; stimulus-responsive hydrogels.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials
  • Colitis, Ulcerative*
  • Drug Delivery Systems
  • Humans
  • Hydrogels* / pharmacology
  • Inflammation / drug therapy

Substances

  • Hydrogels
  • Biocompatible Materials